Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chetrit

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Circulation|September 1, 1991
Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular diseaseM Modan, J Or, A Karasik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1997
The effect of an angiotensin converting enzyme inhibitor on skin microvascular hyperaemia in microalbuminuric insulin-dependent diabetes mellitusG Yosipovitch, J Schneiderman, A Erman, et al.
Circulation|March 1, 1992
Cardiovascular disease in menM Modan, J Or, A Karasik, et al.
The American Journal of Clinical Nutrition|September 1, 1989
Nutritional factors associated with benign breast disease etiology: a case-control studyF Lubin, Y Wax, E Ron, et al.
American Journal of Public Health|April 1, 1992
Prevalence of HIV antibodies in transsexual and female prostitutesB Modan, R Goldschmidt, E Rubinstein, et al.
American Journal of Obstetrics and Gynecology|September 1, 1995
The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinomaJ Menczer, H Krissi, A Chetrit, et al.
Leukemia & Lymphoma|September 1, 1995
A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemiaO Shpilberg, R Blumenthal, O Sofer, et al.
American Journal of Epidemiology|January 11, 2003
Body mass index at age 18 years and during adult life and ovarian cancer riskF Lubin, A Chetrit, L S Freedman, et al.
Blood|March 26, 1999
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young malesA Inbal, D Freimark, B Modan, et al.
Blood|January 15, 1995
One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of JewsO Shpilberg, H Peretz, A Zivelin, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Circulation|September 1, 1991
Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular diseaseM Modan, J Or, A Karasik, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 1, 1997
The effect of an angiotensin converting enzyme inhibitor on skin microvascular hyperaemia in microalbuminuric insulin-dependent diabetes mellitusG Yosipovitch, J Schneiderman, A Erman, et al.
Circulation|March 1, 1992
Cardiovascular disease in menM Modan, J Or, A Karasik, et al.
The American Journal of Clinical Nutrition|September 1, 1989
Nutritional factors associated with benign breast disease etiology: a case-control studyF Lubin, Y Wax, E Ron, et al.
American Journal of Public Health|April 1, 1992
Prevalence of HIV antibodies in transsexual and female prostitutesB Modan, R Goldschmidt, E Rubinstein, et al.
American Journal of Obstetrics and Gynecology|September 1, 1995
The effect of diagnosis and treatment delay on prognostic factors and survival in endometrial carcinomaJ Menczer, H Krissi, A Chetrit, et al.
Leukemia & Lymphoma|September 1, 1995
A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemiaO Shpilberg, R Blumenthal, O Sofer, et al.
American Journal of Epidemiology|January 11, 2003
Body mass index at age 18 years and during adult life and ovarian cancer riskF Lubin, A Chetrit, L S Freedman, et al.
Blood|March 26, 1999
Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young malesA Inbal, D Freimark, B Modan, et al.
Blood|January 15, 1995
One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of JewsO Shpilberg, H Peretz, A Zivelin, et al.
Pageof 12